JENNA DUDUKOVICH: Open Payments
NPI 1700383619 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 31 payments from 7 companies in 2025. Trend: 2023 $365 · 2024 $295 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $222 |
| PFIZER INC. | 9 | $138 |
| Novo Nordisk Inc | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: NURTEC ODT, QULIPTA, VRAYLAR, SHINGRIX, Ozempic, GEMTESA, XIFAXAN, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
